维普中文期刊产品整合服务
289篇 您的检索式:作者名="CONTRERAS G"
    题名 作者 年代 出处 被引量
1A dual positional specific lipoxygenase functions in the generation of flavor compounds during climacteric ripening of apple显示文摘Lipoxygenase(LOX)is an important contributor to the formation of aroma-active C6 aldehydes in apple(Malus×domestica)fruit upon tissue disruption but little is known about its role in autonomously produced aroma volatiles from intact tissue.We explored the expression of 22 putative LOX genes in apple throughout ripening,but only six LOXs were expressed in a ripening-dependent manner.Recombinant LOX1:Md:1a,LOX1:Md:1c,LOX2:Md:2a and LOX2:Md:2b proteins showed 13/9-LOX,9-LOX,13/9-LOX and 13-LOX activity with linoleic acid,respectively.While products of LOX1:Md:1c and LOX2:Md:2b were S-configured,LOX1:Md:1a and LOX2:Md:2a formed 13(R)-hydroperoxides as major products.Site-directed mutagenesis of Gly567 to an alanine converted the dual positional specific LOX1:Md:1a to an enzyme with a high specificity for 9(S)-hydroperoxide formation.The high expression level of the corresponding MdLOX1a gene in stored apple fruit,the genetic association with a quantitative trait locus for fruit ester and the remarkable agreement in regio-and stereoselectivity of the LOX1:Md:1a reaction with the overall LOX activity found in mature apple fruits,suggest a major physiological function of LOX1:Md:1a during climacteric ripening of apples.While LOX1:Md:1c,LOX2:Md:2a and LOX2:Md:2b may contribute to aldehyde production in immature fruit upon cell disruption our results furnish additional evidence that LOX1:Md:1a probably regulates the availability of precursors for ester production in intact fruit tissue.Doreen Schiller Carolina Contreras Jörg Vogt Frank Dunemann Bruno G Defilippi Randolph Beaudry Wilfried Schwab 2015Horticulture Research2015,2,1:6
2Sequential therapies for proliferative lupus nephritis显示文摘Contreras G Pardo V Leclercq B 0,,:2
3Geneticmodification of liver grafts with an adenoviral vector encoding the Bcl-2 geneimproves organ preservation显示文摘Bilbao G Contreras JL Gomez Navarro J Eckhoff DE Mikheeva G Krasnykh V Hynes T Thomas FT Thomas JM Curiel DT 0,,:2
4Sequential therapies for proliferative lupus nephritis显示文摘CONTRERAS G PARDO V LECLEREQ B 2004New Engl J Med2004,,350:1
5An epidemiologic study of early renal replacement therapy after orthotopic liver transplantation显示文摘Contreras G Garces G Quartin AA 2002J Am Soc Nephrol2002,13,1:1
6Influence of race/ ethnicity onresponse to lupus nephritis treatment:the ALMS study显示文摘Isenberg D Appel GB Contreras G etal 2010Rheumatology2010,49,1:1
7Sequential therapies for proliferative lupus nephritis显示文摘Contreras G Pardo V Leclercq B 2004N Engl J Med2004,350,10:1
8Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis 显示文摘Appel GB Contreras G Dooley MA 2009J Am Soc Nephrol2009,20,5:1
9Factors associated with poor outcomes in patients with lupus nephritis显示文摘 Pardo V Cely C 2005Lupus2005,14,:1
10TNF-αand IL-10 promoter polymorphisms,HPV infection,and cervical cancer risk显示文摘Barbisan G Perez LO Contreras A 2012Tumour Biol2012,33,5:1
11Microstmcture and properties of hercynite- magnesia-calcium zirconate refractory mixtures 显示文摘Contreras J E Castillo G A 2005Materials Characterization2005,54,11:1
12Sequential therapies for proliferative lupus nephritis显示文摘CONTRERAS G PARDO V LECLERCQ B 2004N Engl J Med2004,350,10:1
13Factors associated with poor outcomes in patients with lupus nephritis显示文摘 Pardo V Cely C 2005Lupus2005,14,11:1
14Treatment options for severe lupus nephritis 显示文摘LENZ O CONTRERAS G 2004Arch Immunol Ther Exp (Warsz)2004,52,5:1
15Microstructure and properties of hercynite-magnesia-calcium zirconate refractory mixtures 显示文摘Contreras J E Castillo G A 2005Materials Characterization2005,54,11:1
16Sequential therapies for proliferative lupus nephritis显示文摘Contreras G Pardo V Leclercq B 2004N Engl J Med2004,350,10:1
17Sequential ther- apies for proliferative lupus nephritis显示文摘Contreras G Pardo V Leclercq B 2004N Engl J Med2004,350,:1
18Sequential therapies for proliferative lupus nephritis 显示文摘Contreras G Pardo V Leelercq B 2004N Engl J Med2004,350,10:1
19Management of distal anterior cerebral artery aneu- rysms: part I: anatomic variations and clinical presentation显示文摘Abdo M Guinto G Contreras R 2011Contemp Neurosurg2011,33,:1
20Pigment epithelium de- rived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis显示文摘Ek E T Dass C R Contreras K G 2007Cancer Gene Ther2007,14,7:1
返回顶部 每页显示:
共15页 首页 上一页 第1页 下一页 末页 /15 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费